Rep. Gilbert Ray Cisneros, Jr. Purchases Artivion, Inc. (NYSE:AORT) Stock

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Artivion, Inc. (NYSE:AORT). In a filing disclosed on September 04th, the Representative disclosed that they had bought between $1,001 and $15,000 in Artivion stock on July 16th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Mesabi Trust (NYSE:MSB) on 7/31/2026.
• Purchased $1,001 – $15,000 in shares of Praxis Precision Medicines (NASDAQ:PRAX) on 7/30/2026.
• Purchased $15,001 – $50,000 in shares of Alkermes (NASDAQ:ALKS) on 7/30/2026.
• Sold $15,001 – $50,000 in shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 7/30/2026.
• Sold $100,001 – $250,000 in shares of Alibaba Group (NYSE:BABA) on 7/24/2026.
• Sold $1,001 – $15,000 in shares of Adobe (NASDAQ:ADBE) on 7/24/2026.
• Sold $1,001 – $15,000 in shares of Viavi Solutions (NASDAQ:VIAV) on 7/21/2026.
• Purchased $1,001 – $15,000 in shares of SailPoint (NASDAQ:SAIL) on 7/21/2026.
• Purchased $1,001 – $15,000 in shares of Glacier Bancorp (NYSE:GBCI) on 7/21/2026.
• Sold $1,001 – $15,000 in shares of FedEx (NYSE:FDX) on 7/21/2026.

Artivion Stock Down 0.4%

NYSE:AORT traded down $0.12 during midday trading on Tuesday, hitting $25.45. 232,495 shares of the company were exchanged, compared to its average volume of 596,734. The company has a fifty day simple moving average of $26.15 and a 200 day simple moving average of $29.08. The company has a market capitalization of $1.24 billion, a PE ratio of -363.66 and a beta of 1.25. Artivion, Inc. has a fifty-two week low of $19.16 and a fifty-two week high of $48.25. The company has a current ratio of 3.47, a quick ratio of 2.51 and a debt-to-equity ratio of 0.82.

Artivion (NYSE:AORT) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.13 earnings per share for the quarter. The firm had revenue of $125.76 million during the quarter, compared to analysts’ expectations of $119.99 million. Artivion had a negative net margin of 0.67% and a positive return on equity of 6.07%. As a group, equities analysts anticipate that Artivion, Inc. will post 0.45 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on AORT. Stifel Nicolaus set a $45.00 target price on shares of Artivion in a research report on Monday, June 1st. Wall Street Zen lowered shares of Artivion from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Needham & Company LLC reissued a “buy” rating and set a $44.00 target price on shares of Artivion in a research note on Monday, July 20th. Canaccord Genuity Group lifted their price target on shares of Artivion from $39.00 to $40.00 and gave the stock a “buy” rating in a research report on Tuesday, August 18th. Finally, Weiss Ratings lowered Artivion from a “sell (d+)” rating to a “sell (d-)” rating in a research report on Tuesday, August 11th. Seven analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $44.83.

Hedge Funds Weigh In On Artivion

A number of large investors have recently made changes to their positions in the company. BlackRock Inc. bought a new position in Artivion in the 2nd quarter valued at $149,965,000. Conestoga Capital Advisors LLC bought a new stake in Artivion in the first quarter valued at approximately $43,044,000. California State Teachers Retirement System boosted its stake in shares of Artivion by 2,086.7% during the second quarter. California State Teachers Retirement System now owns 1,119,860 shares of the company’s stock valued at $25,163,000 after purchasing an additional 1,068,647 shares during the period. Summit Partners Public Asset Management LLC bought a new position in shares of Artivion in the fourth quarter worth approximately $39,401,000. Finally, Invesco Ltd. boosted its position in Artivion by 211.9% during the 4th quarter. Invesco Ltd. now owns 1,101,239 shares of the company’s stock valued at $50,228,000 after buying an additional 748,119 shares during the period. Institutional investors own 86.37% of the company’s stock.

Insider Buying and Selling

In other Artivion news, CEO James Mackin sold 70,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $28.95, for a total transaction of $2,026,500.00. Following the completion of the transaction, the chief executive officer owned 877,275 shares of the company’s stock, valued at approximately $25,397,111.25. This trade represents a 7.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Jean Holloway sold 977 shares of the business’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $28.49, for a total transaction of $27,834.73. Following the sale, the senior vice president directly owned 184,118 shares of the company’s stock, valued at approximately $5,245,521.82. The trade was a 0.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 122,981 shares of company stock valued at $3,181,531 over the last three months. Corporate insiders own 6.30% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Artivion Company Profile

Artivion, Inc (NYSE: AORT) is a global medical technology company that develops, manufactures and markets implantable tissue products and surgical devices for cardiac and vascular surgery. The company’s portfolio includes biologic implants derived from human and animal tissue, such as allografts and xenografts, as well as synthetic scaffolds and surgical adhesives. These products are designed to repair, reinforce or replace damaged cardiovascular and thoracic tissues during procedures such as aortic repair, heart valve surgery and vascular reconstruction.

Originally founded in 1984 under the name CryoLife, the company rebranded as Artivion in early 2022 to reflect its broader mission in cardiovascular innovation.